Health News Roundup: Zealand says US FDA turns down drug for low blood sugar in infants; Bayer wins latest Roundup cancer trial, ending losing streak and more

Zealand is seeking FDA approval for dasiglucagon, which it plans to use in patients aged seven days or older with congenital hyperinsulinism (CHI), a genetic disorder in which the pancreas secretes too much insulin. Bayer wins latest Roundup cancer trial, ending losing streak Bayer has won a trial in a lawsuit brought by a California man who said he developed cancer from exposure to its Roundup weedkiller, ending what had been a five-trial losing streak for the company in trials over similar claims.

Following is a summary of current health news briefs.

Zealand says US FDA turns down drug for low blood sugar in infants

Zealand Pharma said on Saturday that the U.S. Food and Drug Administration (FDA) had declined to approve its drug for preventing and treating low blood sugar in children with a genetic disorder after finding deficiencies at a third-party manufacturing facility. Zealand is seeking FDA approval for dasiglucagon, which it plans to use in patients aged seven days or older with congenital hyperinsulinism (CHI), a genetic disorder in which the pancreas secretes too much insulin.

Bayer wins latest Roundup cancer trial, ending losing streak

Bayer has won a trial in a lawsuit brought by a California man who said he developed cancer from exposure to its Roundup weedkiller, ending what had been a five-trial losing streak for the company in trials over similar claims. The verdict was handed down on Friday by a jury in San Benito County, California Superior Court, Bayer announced. The company said in a statement that the verdict was "consistent with the evidence in this case that Roundup does not cause cancer and is not responsible for the plaintiff's illness."

Alabama woman with double uterus gives birth to rare twin girls

An Alabama woman with a rare congenital anomaly that results in her having two uteri gave birth to healthy twin girls earlier this week. Kelsey Hatcher and husband Caleb welcomed Roxi Layla on Tuesday night and her sister Rebel Laken on Wednesday morning at the University of Alabama at Birmingham Hospital (UAB), the mother-of-five announced on social media.

India firm denies tampering with tests in probe of cough syrup deaths

India's Maiden Pharmaceuticals, whose cough syrups have been linked to the deaths of children in Gambia, on Saturday denied it had tampered with test samples or bribed officials to do so, as alleged in a complaint under investigation by local health officials. An investigator with the state of Haryana's Food and Drug Administration told Reuters on Friday he was close to finishing a probe into whether a state drug regulator was bribed to switch samples, tested by the Indian government, that contradicted the World Health Organization's findings of toxic substances in the cough syrups.

(With inputs from agencies.)